CeriXClinic Aalborg No1 ApS: Financial statements 2020
CVR: 39659379
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
CeriXClinic Aalborg No1 ApS (CVR 39659379) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 2,144,598 and a net result of DKK 393,300 compared with DKK 952,298 the year before. That is a decrease of 18.6% compared with the year before. Equity in the 2020 report amounted to DKK 1,658,944. The solvency ratio was 39%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,144,598
- Profit/Loss
- DKK 393,300
- Equity
- DKK 1,658,944
- Total Assets
- DKK 4,257,032
- Employees
- 3
Official annual report
How creditworthy is CeriXClinic Aalborg No1 ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
CeriXClinic Aalborg No1 ApS has published its annual report for 2019. Gross profit came to DKK 2,635,249, and the net result was DKK 952,298.
As of May 26, 2020, Kjenneth Wilhelm Leclaire-Rosenblum is registered as director of CeriXClinic Aalborg No1 ApS.
About CeriXClinic Aalborg No1 ApS
CeriXClinic Aalborg No1 ApS was a Danish company of the type Anpartsselskab based in Aalborg, founded in 2018. The company has been dissolved on 1 August 2024. The company was registered under the industry Praktiserende speciallæger. The company was previously named CeriXCliniC Aalborg NO1 ApS. The company has 10 employees (2024). In 2023, the company reported a gross profit of DKK 1,237,998 and a net result of DKK -2,520,200 compared with DKK -1,886,433 the year before. Equity in the 2023 report amounted to DKK -3,902,184.
